Table 2.
Treatment regimens of patients.
| Patient No. | Onset type | Time from onset to initial treatment | Prior treatment | Efficacy of prior treatment | Concomitant medications |
|---|---|---|---|---|---|
| P1 | Acute | 21 days | IVIG, GCs | Effective | GCs |
| P2 | Chronic | 2 years | GCs, PE | Effective | GCs |
| P3 | Acute | 2 months | IVIG, GCs | Effective | HCQ |
| P4 | Acute | 6 months | IVIG, GCs | Effective | Tac |
| P5 | Acute | 2 months | IVIG, PE | Effective | – |
| P6 | Chronic | 1 year | PE, RTX | Effective | – |
| P7 | Acute | 1 months | IVIG | None | – |
| P8 | Acute | 10 days | IVIG, GCs | Effective | GCs |
| P9 | Chronic | 2 years | Tac | Effective | Tac |
| P10 | Acute | 13 days | PE, RTX | Effective | – |
| P11 | Chronic | 1 year | – | Effective | – |
| P12 | Chronic | 8 months | IVIG | Effective | MMF |
IVIG, intravenous immunoglobulin; GCs, Corticosteroids; PE, plasma exchange;RTX, rituximab;Tac, Tacrolimus; HCQ, hydroxychloroquine; MMF, mycophenolate mofetil.